Aarti Drugs

Aarti Drugs shares jump 2% as new plant begins operations

Aarti Drugs share price jumps 6% as Q4 EBITDA rises 8.9% YoY to Rs 93.4 crore

Aarti Drugs shares surge 15% after receiving EIR from USFDA for API plant in Tarapur

Aarti Drugs shares fall over 2% following poor Q2 FY25 results

Aarti Drugs stock in focus as Q2 FY25 results show 6.3% revenue decline to ₹543.09 crore; profit falls 12.1% YoY to ₹40.99 crore

Aarti Drugs Q2 FY25 Results: Revenue declines 6.3% YoY to Rs 543 crore, Profit falls 12% YoY

Aarti Drugs Limited has reported its financial results for the second quarter of FY25, showing a decline in both revenue and profit compared to the same period last year.

Aarti Drugs shares surge over 2% after arm gets GMP certificate from UK MHRA

Aarti Drugs’ subsidiary Pinnacle Life Science receives GMP certificate from UK MHRA

Aarti Drugs Buyback Opens Today, Set to Close on 18th September 2024

Aarti Drugs announces share buyback at 60% premium

Shares of Aarti Drugs surged over 9% following the buyback announcement.

Aarti Drugs shares surge 10% ahead of board meeting on sixth buyback plan